Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enfamil Premature LIPIL

This article was originally published in The Tan Sheet

Executive Summary

New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1"The Tan Sheet" April 29, 2002, p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11...

New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1 (Also see "DHA, ARA Benefit Preterm Infants, Research Shows; Formulas On Horizon" - Pink Sheet, 29 Apr, 2002.), p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel